Approvals in 2019: international review and a new agnostic molecular entity
Sign Up to like & getrecommendations! Published in 2020 at "Nature Reviews Clinical Oncology"
DOI: 10.1038/s41571-020-0336-8
Abstract: In 2019, the FDA Oncology Center of Excellence (OCE) approved 11 new drugs and biologic agents, 30 supplemental drug and biologic applications, and four biosimilar applications in oncology. These included two landmark approvals involving collaboration… read more here.
Keywords: review new; 2019 international; new agnostic; approvals 2019 ... See more keywords